Table 4 Baseline characteristics of the study subjects for Analysis 2.

From: Risk factors for the development of idiopathic macular hole: a nationwide population-based cohort study

Variables

Total (N = 1,735,189)

Macular hole development

No (N = 1,733,622)

Yes (N = 1567)

1. Demographic factors

Age, years, mean ± SD

60.92 ± 7.25

60.92 ± 7.25

62.70 ± 5.88

Age group, no. (%)

50–54 years

416,317 (23.99)

416,182 (24.01)

135 (8.62)

55–59 years

419,626 (24.18)

419,299 (24.19)

327 (20.87)

60–64 years

401,424 (23.13)

400,845 (23.12)

579 (36.95)

65–69 years

210,769 (12.15)

210,484 (12.14)

285 (18.19)

70–74 years

206,741 (11.91)

206,546 (11.91)

195 (12.44)

75–79 years

80,312 (4.63)

80,266 (4.63)

46 (2.94)

Income, no. (%)*

Q1 (lowest)

399,640 (23.03)

399,284 (23.03)

356 (22.72)

Q2

314,892 (18.15)

314,653 (18.15)

239 (15.25)

Q3

411,337 (23.71)

410,956 (23.71)

381 (24.31)

Q4 (highest)

609,320 (35.12)

608,729 (35.11)

591 (37.72)

2. Systemic comorbidities

Hypertension, no. (%)

No

1,131,954 (65.24)

1,130,952 (65.24)

1002 (63.94)

Yes

603,235 (34.76)

602,670 (34.76)

565 (36.06)

Dyslipidemia, no. (%)

No

1,098,111 (63.28)

1,097,140 (63.29)

971 (61.97)

Yes

637,078 (36.72)

636,482 (36.71)

596 (38.03)

Stroke, no. (%)

No

1,714,441 (98.80)

1,712,892 (98.80)

1,549 (98.85)

Yes

20,748 (1.20)

20,730 (1.20)

18 (1.15)

Heart diseases, no. (%)*

No

1,683,166 (97.00)

1,681,663 (97.00)

1,503 (95.92)

Yes

52,023 (3.00)

51,959 (3.00)

64 (4.08)

Chronic kidney disease, no. (%)

No

1,628,826 (93.87)

1,627,373 (93.87)

1,453 (92.72)

Yes

106,363 (6.13)

106,249 (6.13)

114 (7.28)

3. Behavioral factors

Smoking history, no. (%)

Never smoked

1,677,557 (96.68)

1,676,027 (96.68)

1,530 (97.64)

Past smoker

18,764 (1.08)

18,747 (1.08)

17 (1.08)

Current smoker

38,868 (2.24)

38,848 (2.24)

20 (1.28)

Drinking habit, no. (%)

None

1,484,984 (85.58)

1,483,604 (85.58)

1380 (88.07)

Mild

236,033 (13.60)

235,852 (13.60)

181 (11.55)

Heavy

14,172 (0.82)

14,166 (0.82)

6 (0.38)

Regular physical activity, no. (%)

No

1,348,872 (77.74)

1,347,651 (77.74)

1221 (77.92)

Yes

386,317 (22.26)

385,971 (22.26)

346 (22.08)

Body mass index, no (%)

< 18.5 kg/m2

40,543 (2.34)

40,509 (2.34)

34 (2.17)

18.5 to < 23 kg/m2

669,478 (38.58)

668,872 (38.58)

606 (38.67)

23 to < 25 kg/m2

454,396 (26.19)

453,969 (26.19)

427 (27.25)

25 to < 30 kg/m2

508,906 (29.33)

508,456 (29.33)

450 (28.72)

≥ 30 kg/m2

61,866 (3.57)

61,816 (3.57)

50 (3.19)

4. Reproductive factors

Age at menarche, mean ± SD

16.12 ± 2.02

16.12 ± 2.02

16.23 ± 2.48

Age at menarche in group, no. (%)

< 14 years

115,015 (6.63)

114,923 (6.63)

92 (5.87)

14–15 years

579,180 (33.38)

578,668 (33.38)

512 (32.67)

16–17 years

654,397 (37.71)

653,803 (37.71)

594 (37.91)

≥ 18 years

386,597 (22.28)

386,228 (22.28)

369 (23.55)

Age at menopause, mean ± SD*

50.70 ± 3.78

50.70 ± 3.78

50.92 ± 4.03

Age at menopause in group, no. (%)

< 45 years

82,441 (4.75)

82,360 (4.75)

81 (5.170)

45–49 years

399,423 (23.02)

399,083 (23.02)

340 (21.70)

50–54 years

1,029,066 (59.31)

1,028,181 (59.31)

885 (56.48)

≥ 55 years

224,259 (12.92)

223,998 (12.92)

261 (16.66)

Parity, no. (%)

Nulliparous

31,956 (1.84)

31,941 (1.84)

15 (0.96)

1 child

152,356 (8.78)

152,257 (8.78)

99 (6.32)

≥ 2 children

1,550,877 (89.38)

1,549,424 (89.37)

1,453 (92.72)

Hormone replacement therapy, no. (%)

Never used

1,379,231 (79.49)

1,378,017 (79.49)

1214 (77.47)

< 2 years

163,134 (9.40)

162,970 (9.40)

164 (10.47)

2 to < 5 years

69,820 (4.02)

69,757 (4.02)

63 (4.02)

≥ 5 years

55,306 (3.19)

55,232 (3.19)

74 (4.72)

Unknown

67,698 (3.90)

67,646 (3.90)

52 (3.32)

Oral contraceptive pill use, no. (%)

Never used

1,399,964 (80.68)

1,398,704 (80.68)

1260 (80.41)

< 1 year

155,170 (8.94)

155,028 (8.94)

142 (9.06)

≥ 1 year

98,230 (5.66)

98,143 (5.66)

87 (5.55)

Unknown

81,825 (4.72)

81,747 (4.72)

78 (4.98)

  1. SD standard deviation, Q quartile.
  2. *p-value < 0.05; p-value < 0.01; p-value < 0.001.